Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study

被引:0
|
作者
Ziyi Xu
Xuezhi Hao
Ke Yang
Qi Wang
Jing Wang
Lin Lin
Fei Teng
Junling Li
Puyuan Xing
机构
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[2] Cancer Hospital of Huanxing,Department of Medical Oncology
[3] Beijing Chaoyang Sanhuan Hospital,Department of Medical Oncology
关键词
Non-small cell lung cancer; Immune checkpoint inhibitor; Immunotherapy rechallenge;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3081 / 3089
页数:8
相关论文
共 50 条
  • [1] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Xu, Ziyi
    Hao, Xuezhi
    Yang, Ke
    Wang, Qi
    Wang, Jing
    Lin, Lin
    Teng, Fei
    Li, Junling
    Xing, Puyuan
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3081 - 3089
  • [2] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Feng, Jia
    Chen, Xinyi
    Wei, Jiayan
    Weng, Yiming
    Wang, Jingsong
    Wang, Tong
    Song, Qibin
    Min, Peng
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [3] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Jia Feng
    Xinyi Chen
    Jiayan Wei
    Yiming Weng
    Jingsong Wang
    Tong Wang
    Qibin Song
    Peng Min
    [J]. Scientific Reports, 14
  • [4] Efficacy and safety analysis of immune checkpoint inhibitor rechallenge therapy in locally advanced and advanced non-small cell lung cancer: a retrospective study
    Yan, Xiaoqi
    Zhao, Luqing
    Wu, Fei
    Shen, Bo
    Zhou, Guoren
    Feng, Jifeng
    Yue, Chao
    Zhu, Jingni
    Yu, Shaorong
    Zhu, Jingni
    [J]. JOURNAL OF THORACIC DISEASE, 2024, 16 (03) : 1787 - 1803
  • [5] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    [J]. THORACIC CANCER, 2024, 15 (05) : 419 - 426
  • [6] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [7] The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Kudo, Kenichiro
    Minami, Daisuke
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (08) : 762 - 765
  • [8] The effect and safety of an immune checkpoint inhibitor rechallenge in non-small cell lung cancer.
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Kudo, Kenichiro
    Minami, Daisuke
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
    Takeuchi, Eiji
    Kondo, Kensuke
    Okano, Yoshio
    Kunishige, Michihiro
    Kondo, Yoshihiro
    Kadota, Naoki
    Machida, Hisanori
    Hatakeyama, Nobuo
    Naruse, Keishi
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Shinohara, Tsutomu
    Nishioka, Yasuhiko
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3139 - 3147
  • [10] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
    Eiji Takeuchi
    Kensuke Kondo
    Yoshio Okano
    Michihiro Kunishige
    Yoshihiro Kondo
    Naoki Kadota
    Hisanori Machida
    Nobuo Hatakeyama
    Keishi Naruse
    Hirokazu Ogino
    Hiroshi Nokihara
    Tsutomu Shinohara
    Yasuhiko Nishioka
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3139 - 3147